Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s – Xconomy
Xconomy |
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson's
Xconomy A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson's disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal. Global rights to Parkinson's treatment VY-AADC01 … Sanofi walks away from Voyager's phase 2/3 Parkinson's gene therapy |
